The EGC Team attended the BioVenture Nexus conference in Los Angeles. BioVenture Nexus is the premier event for innovation and networking in the Synthetic Biology, Biotech Industry, Life Science, Food Tech, and AI in Biology.
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.
Related Posts
October 7, 2024
Eva Garland Consulting Awarded Contract to Lead the National Cancer Institute’s SBIR/STTR Program
Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA),…
October 2, 2024
October 2024 Newsletter
EGC’s October newsletter celebrates the success of our client, Dignify Therapeutics, and showcases our Fall Grant Webinar Series with two upcoming…
October 1, 2024
EGC Wins 2024 Growth Accelerator Fund Competition Stage Two
Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA),…
September 24, 2024
Government Accounting & Legal Compliance Webinar Series: Intellectual Property Overview
This webinar provided a nuts-and-bolts overview of legal frameworks designed to protect your ideas and valuable business information, with insights…